[
  {
    "ts": null,
    "headline": "Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More",
    "summary": "CMRX and JAZZ are in the spotlight this week following an acquisition agreement.",
    "url": "https://finnhub.io/api/news?id=c4c45de3afe5f51f0934aea91a70f73591142823dbc66bfbc5546d6e14122cd8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741291200,
      "headline": "Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More",
      "id": 133193276,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CMRX and JAZZ are in the spotlight this week following an acquisition agreement.",
      "url": "https://finnhub.io/api/news?id=c4c45de3afe5f51f0934aea91a70f73591142823dbc66bfbc5546d6e14122cd8"
    }
  },
  {
    "ts": null,
    "headline": "Update: Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court",
    "summary": "(Updates with Moderna and BioNTech's responses in the fifth and sixth paragraphs, along with the lat",
    "url": "https://finnhub.io/api/news?id=e7c19d026f88f4890e63c711bf304962101ac8d88d0d4b74fa6793c4c52336ca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741289284,
      "headline": "Update: Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court",
      "id": 133193278,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "(Updates with Moderna and BioNTech's responses in the fifth and sixth paragraphs, along with the lat",
      "url": "https://finnhub.io/api/news?id=e7c19d026f88f4890e63c711bf304962101ac8d88d0d4b74fa6793c4c52336ca"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Insider Buy Signal",
    "summary": "Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore more details here.",
    "url": "https://finnhub.io/api/news?id=aeec8e1589a6ccd1a802a2d01078554d33d2b75e7b16791b7354947dd29365c2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741277479,
      "headline": "Moderna: Insider Buy Signal",
      "id": 133071424,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/649781200/image_649781200.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore more details here.",
      "url": "https://finnhub.io/api/news?id=aeec8e1589a6ccd1a802a2d01078554d33d2b75e7b16791b7354947dd29365c2"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Moderna Stock Soared 16% on Wednesday",
    "summary": "The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.",
    "url": "https://finnhub.io/api/news?id=f7f4256d65939a9ccb49ff4eddf3d3849ac1f728e2da4e068276e077bfe46b80",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741270380,
      "headline": "Here's Why Moderna Stock Soared 16% on Wednesday",
      "id": 133193280,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The surge in MRNA stock comes after some SEC filings show that company insiders bought shares worth $6 million.",
      "url": "https://finnhub.io/api/news?id=f7f4256d65939a9ccb49ff4eddf3d3849ac1f728e2da4e068276e077bfe46b80"
    }
  },
  {
    "ts": null,
    "headline": "Why Moderna, Inc. (MRNA) Went Up on Wednesday",
    "summary": "We recently compiled a list of the 10 Stocks Lead Wednesday’s Charge, Mirror Broader Gains. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other stocks. US shares stayed firmer on Wednesday, with all major indices finally eking out gains as President Donald Trump softened on trade […]",
    "url": "https://finnhub.io/api/news?id=5ec8f46715cc3e70ca66c925e2a7a468e59eaf1ab3c56c60a534e1a2fca99f31",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741265713,
      "headline": "Why Moderna, Inc. (MRNA) Went Up on Wednesday",
      "id": 133193282,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Stocks Lead Wednesday’s Charge, Mirror Broader Gains. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other stocks. US shares stayed firmer on Wednesday, with all major indices finally eking out gains as President Donald Trump softened on trade […]",
      "url": "https://finnhub.io/api/news?id=5ec8f46715cc3e70ca66c925e2a7a468e59eaf1ab3c56c60a534e1a2fca99f31"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out",
    "summary": "Moderna, Inc.'s stock soars 16% amid patent win over Pfizer/BioNTech, while legal battles highlight mRNA challenges. Click for my MRNA update.",
    "url": "https://finnhub.io/api/news?id=eb0469c290de50367bc9b0a242d076cd8837ddfd4949e727f50661bbabca3894",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741257150,
      "headline": "Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out",
      "id": 133059585,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2183146726/image_2183146726.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "Moderna, Inc.'s stock soars 16% amid patent win over Pfizer/BioNTech, while legal battles highlight mRNA challenges. Click for my MRNA update.",
      "url": "https://finnhub.io/api/news?id=eb0469c290de50367bc9b0a242d076cd8837ddfd4949e727f50661bbabca3894"
    }
  }
]